Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study of Thrombosis / Bleeding Incidence and Prophylaxis Trends

NCT05396157 is registered in ClinicalTrials.gov with Mount Sinai Hospital, Canada as lead sponsor.

NCT NCT05396157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05396157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study of Thrombosis / Bleeding Incidence and Prophylaxis Trends
Lead sponsor
Mount Sinai Hospital, Canada
Phase
Observational
Overall status
Active, not recruiting
Start date
November 1, 2021
Completion date
December 31, 2026
Enrollment
813 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding hemorrhage, hematologic malignancy, thrombocytopenia, thrombosis, venous, venous thromboembolic disease